Paper Summary

Plain-language summaries of new research papers in bioinformatics, computational biology and life sciences.

Bioinformatics | Genomics | News | Paper Summary | Trending

Scientists Create a Near-Perfect Telomere-to-Telomere Diploid Human Genome Benchmark for Personalized Genomics
ByAnchal Negi August 16, 2026October 22, 2026

For years, genomics has had a dirty little secret: even our best reference genomes have gaps. Now, a large international team of the National Human Genome Research Institute (NHGRI) at the NIH, along with the National Institute of Standards and Technology (NIST), has closed most of those gaps for good. Their new study introduces what…

Read More Scientists Create a Near-Perfect Telomere-to-Telomere Diploid Human Genome Benchmark for Personalized Genomics
Bioinformatics | News | Paper Summary | PPI | RNA | Trending | Virus

Scientists Reveal How the Influenza A Virus Rewires Human Cells from the Inside
ByAnchal Negi August 8, 2026October 22, 2026

Every winter, the influenza A virus infects millions of people. In a handful of cells, it manages to do something very hard for scientists to observe: it enters a human cell, releases its own genetic material, and starts rewiring almost everything around it. We have known for decades that this rewiring happens, but seeing exactly…

Read More Scientists Reveal How the Influenza A Virus Rewires Human Cells from the Inside
AI | Bioinformatics | Drug Discovery | News | Paper Summary | Tools | Trending

Meet Robin: A Multi-Agent AI Framework for Scientific Discovery
ByAnchal Negi August 6, 2026October 22, 2026

A team from the FutureHouse, University of Oxford and Fordham University published a paper in Nature describing something that sounds like science fiction but is very real lab work: an AI system that proposed, tested, and refined a new drug candidate for an eye disease almost entirely on its own. The system is called Robin,…

Read More Meet Robin: A Multi-Agent AI Framework for Scientific Discovery
AI | Bioinformatics | News | OMICS | Paper Summary | Trending

Meet BiOmics: The AI Agent Bridging Data and Biological Meaning
ByAnchal Negi July 18, 2026October 22, 2026

Biology today produces more data than anyone knows what to do with. Sequencers spit out genomes, single-cell experiments generate massive expression matrices, proteomics platforms churn out thousands of protein measurements, and yet, turning all of that into an actual understanding of what is happening inside a cell or a disease remains painfully slow. A team…

Read More Meet BiOmics: The AI Agent Bridging Data and Biological Meaning
AMR Alert | Drug Discovery | Health | News | Paper Summary | Structural Biology | Trending

Scientists Discover TB’s Metabolic “Control Switch” — A New Target for Tuberculosis Drugs
BySaniya Sayyed July 13, 2026October 22, 2026

The interdisciplinary team, spanning researchers from the University of Surrey, Imperial College London, IISc, and others, discovered Virulence Associated Dikinase (VadK), which evolved from pyruvate phosphate dikinase to histidine kinase. It regulates the methylcitrate cycle used by Mycobacterium tuberculosis to process energy sources from host lipids. Without ΔvadK mutants, the TB bacteria failed to grow…

Read More Scientists Discover TB’s Metabolic “Control Switch” — A New Target for Tuberculosis Drugs
AI | Health | Medical Informatics | News | Paper Summary | Tools | Trending

ATHENA-R1: A Reinforcement Learning AI Agent for Smarter Drug and Treatment Decisions
ByAnchal Negi July 13, 2026October 22, 2026

Picking the right treatment for a patient is rarely a one-step decision. A doctor has to think about the disease, the patient’s other health conditions, the drugs they’re already taking, possible interactions, and warnings that keep changing as new research comes out. It’s a slow, careful process of gathering facts before concluding. A team of…

Read More ATHENA-R1: A Reinforcement Learning AI Agent for Smarter Drug and Treatment Decisions
Drug Discovery | Generative Biology | News | Paper Summary | Structural Biology | Tools | Trending

From Fragment to Drug Candidate: How Sesame Uses AI to Build Better Molecules
ByAnchal Negi July 2, 2026October 22, 2026

There’s a moment in drug discovery that every medicinal chemist knows well. You’ve found a hit, a molecule that binds to your target, shows early promise, but isn’t quite ready. It might be too big, too greasy, or just structurally awkward. So you strip it down. You keep the core that’s doing the good work,…

Read More From Fragment to Drug Candidate: How Sesame Uses AI to Build Better Molecules
AI | AMR Alert | Bioinformatics | Machine Learning | News | Paper Summary | Trending

Can Machine Learning Forecast Antibiotic Resistance Trends Across the Globe?
BySaniya Sayyed June 30, 2026October 22, 2026

Antimicrobial resistance (AMR) has quietly become one of the defining health crises of our time, undermining the effectiveness of life-saving medicines and putting decades of medical progress at risk. Drug-resistant infections already claim more than 1 million lives each year and contribute to nearly 5 million deaths globally, with projections pointing to a staggering 39 million…

Read More Can Machine Learning Forecast Antibiotic Resistance Trends Across the Globe?
AI | Bioinformatics | Generative Biology | News | Paper Summary | Protein Design | Tools | Trending

From Natural Language to Biological Design: How Proto Powers Generative Biology
ByAnchal Negi June 27, 2026October 22, 2026

A structured program produced genetic sequences that don’t exist in nature — then those sequences were built, tested in human cells, and found to work. That single result points to something larger: biology is beginning to look less like a collection of disconnected experiments and more like a programmable system. Proto is the language making…

Read More From Natural Language to Biological Design: How Proto Powers Generative Biology
AI | Bioinformatics | News | Paper Summary | Structural Biology | Tools | Trending

DECAF: Genesis AI-Based Framework for Faster and Computationally Efficient All-Atom Protein Cofolding
BySaniya Sayyed June 25, 2026October 22, 2026

The high computational cost of generating accurate atomic-level biomolecular structures remains a major challenge in AI-driven drug discovery. Researchers from Genesis Molecular AI, MIT, Carnegie Mellon University, and Imperial College London have developed DeCAF (Denoiser Cofolding All-Atom Flowmap), a framework that distills diffusion-based cofolding models into faster flow-based models capable of generating high-quality protein and…

Read More DECAF: Genesis AI-Based Framework for Faster and Computationally Efficient All-Atom Protein Cofolding
AI | Machine Learning | News | Paper Summary | Structural Biology | Tools | Trending

PPIscreenML: A Rigorous Machine Learning Approach to Screening Protein-Protein Interactions with AF2
ByAnchal Negi June 11, 2026October 22, 2026

Every second, thousands of proteins inside your cells are bumping into each other, forming fleeting partnerships, and splitting apart again. These protein-protein interactions (PPIs) are the invisible handshakes that keep your heart beating, your immune system fighting, and your DNA replicating. Get them wrong, and disease follows. But here’s the problem: figuring out which proteins…

Read More PPIscreenML: A Rigorous Machine Learning Approach to Screening Protein-Protein Interactions with AF2
AI | News | Paper Summary | PLM | Structural Biology | Tools | Trending

Meet FrustrAI-Seq: Proteome-Wide Frustration Profiling Without Structural Inputs
ByAnchal Negi June 4, 2026October 22, 2026

Proteins are remarkable molecules. They fold, bend, bind, and catalyze, all while balancing an internal tension that most biology textbooks barely mention. That tension has a name: local energetic frustration. And a new study from researchers at Helmholtz Munich, the Technical University of Munich, and the Barcelona Supercomputing Center has just made it dramatically easier…

Read More Meet FrustrAI-Seq: Proteome-Wide Frustration Profiling Without Structural Inputs
AI | Bioinformatics | LLM | NGS | Paper Summary | Tools | Trending

What If an AI Agent Could Handle All Your Bioinformatics Plots? Meet PlotGDP
BySaniya Sayyed April 27, 2026October 22, 2026

The research team affiliated with Sun Yat Sen University in Guangzhou engineered PlotGDP, an AI-based web server tool designed to assist people with various bioinformatics plotting tasks, with no coding or environment deployment required. Biomedical research catalyzes progress in medicine, diagnostics, and therapies. Thousands of papers are published on a daily basis across journals. Without…

Read More What If an AI Agent Could Handle All Your Bioinformatics Plots? Meet PlotGDP
AI | Bioinformatics | News | Paper Summary | Protein Design | Tools | Trending

ROCKET Transforms AlphaFold2 into an Experiment-Driven Structure Modeling Tool
BySaniya Sayyed April 19, 2026October 22, 2026

Researchers at the University of Cambridge, Columbia University, and partner institutions have introduced ROCKET, a novel framework that extends AlphaFold2 by integrating experimental data, such as cryo-EM and x-ray crystallography, directly into structure prediction. It fuses machine learning priors with traditional approaches, allowing accurate modeling even at low resolution, noisy, or frontier datasets. Rocket was…

Read More ROCKET Transforms AlphaFold2 into an Experiment-Driven Structure Modeling Tool
AI | Bioinformatics | News | NGS | Paper Summary | Tools | Trending

Scientists Introduce ‘CLASSIC’ Platform Enabling AI-Driven Genetic Circuit Design
ByJainab Shaikh April 2, 2026October 22, 2026

Researchers from Rice and Boston universities developed CLASSIC, a platform that combines long- and short-read sequencing to measure over 100,000 multi-gene circuits in human cells. The resulting data was used to train machine learning models to predict circuit behavior and uncover rules for part compositions, accelerating the design-build-test-learn cycle in synthetic biology. Limitations of the…

Read More Scientists Introduce ‘CLASSIC’ Platform Enabling AI-Driven Genetic Circuit Design
AI | Bioinformatics | Drug Discovery | News | Paper Summary | Structural Biology | Tools | Trending

IntelliFold-2: An Open Source Alternative to AlphaFold 3 With Better Accuracy and Robustness
BySaniya Sayyed March 30, 2026October 22, 2026

The innovators behind intelliFold-2 at IntelliGen AI emphasize that IntelliFold-2 is designed as a state-of-the-art open source alternative to AlphaFold3 with stronger performance in therapeutically relevant tasks like antibody-antigen docking and protein-ligand co-folding. The architectural refinements, like latent scaling and atom attention, along with algorithmic innovations such as policy-guided diffusion and difficulty-aware loss reweighting, help…

Read More IntelliFold-2: An Open Source Alternative to AlphaFold 3 With Better Accuracy and Robustness
AI | Bioinformatics | News | Paper Summary | Protein Design | Structural Biology | Tools | Trending

Transforming All-Atom De Novo Design of Protein Using RFdiffusion3
BySaniya Sayyed March 26, 2026October 22, 2026

A major collaboration led by David Baker’s group at the Institute for Protein Design (UW) introduced RFdiffusion3 (RFD3), a next-generation version of the originally developed RFdiffusion. It is a generative diffusion model for general-purpose de novo protein design that works at the all-atom level, allowing precise modelling of hydrogen bonds, ligands, and nucleic acid interactions….

Read More Transforming All-Atom De Novo Design of Protein Using RFdiffusion3
AI | Bioinformatics | Health | Medical Informatics | News | Paper Summary | Trending

MHub.ai: Standardizing AI for Reproducible Medical Imaging
BySaniya Sayyed February 14, 2026October 22, 2026

An inter-institutional collaboration across the US, Germany, and the Netherlands introduces MHub.ai, an accessibility and reproducibility-prioritizing, open source platform for standardized access to AI models for automating and accelerating research in medical imaging. AI as a Revolution in Medical Imaging and Issues with Its Usability Medical imaging has been a revolution in the medical field…

Read More MHub.ai: Standardizing AI for Reproducible Medical Imaging
AI | Bioinformatics | Drug Discovery | Machine Learning | News | Paper Summary | Tools | Trending

ConGLUDe: Toward General-Purpose Foundation Models for Drug Discovery
ByJainab Shaikh February 11, 2026October 22, 2026

Researchers from Johannes Kepler University Linz, Austria, and Merck HealthCare, Germany, developed ConGLUDe (Contrastive Geometric Learning for Unified Computational Drug Design), an AI-based model for drug discovery. The model combines structure-based and ligand-based drug designs into one system instead of treating them separately. It can predict protein-ligand interactions, find binding pockets, and perform virtual screening even when…

Read More ConGLUDe: Toward General-Purpose Foundation Models for Drug Discovery
AI | Bioinformatics | Drug Discovery | Machine Learning | News | Paper Summary | Tools | Trending

DrugCLIP Enables High-Throughput Virtual Screening Across the Human Proteome
BySaniya Sayyed February 6, 2026October 22, 2026

Researchers at Tsinghua University have introduced DrugCLIP, a contrastive learning framework that enables ultrafast and accurate virtual screening at a genome-wide scale. Published in Science, it is validated against 5-HT2AR, TRIP12, and NET, and it enables virtual screening at the genome scale, up to seven orders of magnitude faster than docking methods. Why is there…

Read More DrugCLIP Enables High-Throughput Virtual Screening Across the Human Proteome
Bioinformatics | News | Paper Summary | Structural Biology | Tools | Trending

Beyond the Sequence: How FoldMason is Redefining Multiple Protein Structure Alignment at Scale
BySaniya Sayyed February 4, 2026October 22, 2026

The authors at Seoul National University developed FoldMason, a free, open-source, progressive Multiple Structural Alignment (MSTA) method published in Science that uses a structural alphabet from Foldseek and aligns hundreds of thousands of protein structures. Achieving two orders of magnitude faster than other methods, when applied to Flaviviridae glycoproteins, it supported phylogenetic analysis below the…

Read More Beyond the Sequence: How FoldMason is Redefining Multiple Protein Structure Alignment at Scale
Bioinformatics | Cancer | News | Paper Summary | Structural Biology | Trending

De Novo Peptide Binder Generation: How moPPIt Targets ‘Undruggable’ Proteins
BySaniya Sayyed February 2, 2026October 22, 2026

Authors from the University of Pennsylvania and others innovated the motif-specific PPI targeting algorithm (moPPIt), a computational framework that integrates BindEvaluator along with Multi-Objective Guided Discrete Flow Matching (MOG-DFM) to design peptides that can selectively bind functional motifs without needing structural priors. It works directly from sequence data instead of requiring known 3D structures, making…

Read More De Novo Peptide Binder Generation: How moPPIt Targets ‘Undruggable’ Proteins
AI | Bioinformatics | Computational Models | News | Paper Summary | Trending

Generating DNA Sequences Using AI: DNA-Diffusion Promises Effective Gene Therapy
BySaniya Sayyed January 31, 2026October 22, 2026

The researchers at Broad Institute and Mass General Brigham in Nature Genetics propose DNA-Diffusion, the first ever generative diffusion framework trained on DNA accessibility data to design cis-regulatory elements (CREs) with activity specific to cell-types. The authors validated these synthetic DNA elements using STARR-seq and EXTRA-seq (Endogenous expression Targeted Regulatory Activity sequencing) against blood cancer…

Read More Generating DNA Sequences Using AI: DNA-Diffusion Promises Effective Gene Therapy
Bioinformatics | Genomics | News | OMICS | Paper Summary | Trending

PanMAN Enables Scalable High-Resolution Pangenome Analysis
BySaniya Sayyed January 22, 2026October 22, 2026

The study led by researchers from UC San Diego and UC Santa Cruz introduces PanMAN, a new data structure designed to overcome the limitations of current pangenome formats. Applied to SARS-CoV-2,PanMAN compressed the entire genome sequence into just 366 MB while still preserving all the variations. What is Pangenomics? Studying genomes helps us in understanding…

Read More PanMAN Enables Scalable High-Resolution Pangenome Analysis
AI | Bioinformatics | Biomedical Engineering | Drug Discovery | News | Paper Summary | Protein Design | Tools | Trending

CleaveNet Enables Scalable and Targeted Protease Substrate Design for Diagnostics and Therapeutics
BySaniya Sayyed January 13, 2026October 22, 2026

Scientists from MIT and Microsoft Research present CleaveNet, an AI-based pipeline that merges predictive and generative modeling for end-to-end peptide (short protein) design. By validating the system on matrix metalloproteinases (MMPs), the team demonstrates that AI can uncover novel cleavage motifs, engineer selective substrates, and overcome ever-existing challenges in protease promiscuity. Balancing Efficiency, Selectivity, and…

Read More CleaveNet Enables Scalable and Targeted Protease Substrate Design for Diagnostics and Therapeutics
AI | Drug Discovery | Machine Learning | News | Paper Summary | Tools | Trending

Advancing Peptide Therapeutics with PeptiVerse’s Unified Prediction Framework
ByJainab Shaikh January 11, 2026October 22, 2026

Researchers at the University of Pennsylvania developed PeptiVerse, a single platform that predicts drug-related properties of therapeutic peptides using either amino acid sequences or chemically modified SMILES representations. The platform uses pretrained protein and chemical language models to make quick and precise predictions for various peptide properties. With a web-based interface and an open-source implementation,…

Read More Advancing Peptide Therapeutics with PeptiVerse’s Unified Prediction Framework
Bioinformatics | Cell | Deep Learning | Genomics | News | Paper Summary | Trending

Human Genome in 4D: Mapping Structure, Function, and Dynamics
ByAnchal Negi January 10, 2026October 22, 2026

An integrated atlas of the human 4D genome just dropped, and it is breathtaking in its ambition. In a massive consortium effort, researchers from various institutions, including UMass Chan Medical School, Northwestern University, and other collaborators, have assembled one of the most comprehensive views to date of how the human genome folds and functions in…

Read More Human Genome in 4D: Mapping Structure, Function, and Dynamics
AI | Bioinformatics | Cancer | Drug Discovery | Machine Learning | News | Paper Summary | Structural Biology | Tools | Trending

Beyond Tertiary Structures: SMRTnet’s Novel Approach to RNA Drug Discovery
ByJainab Shaikh January 8, 2026October 22, 2026

Researchers from Tsinghua University and Peking University in China developed the SMRTnet tool, which employs a deep-learning approach to identify interactions between small molecules and RNA, eliminating the need for RNA tertiary structure information. By combining RNA secondary structure and multimodal neural networks, the research showed that SMRTnet outperformed other prediction tools and validated its…

Read More Beyond Tertiary Structures: SMRTnet’s Novel Approach to RNA Drug Discovery
Bioinformatics | Biotech | Cloud Computing | News | Paper Summary | Tools | Trending

CoLabPCR: A One-stop Tool for Precise and Reproducible Primer Design
ByJainab Shaikh January 7, 2026October 22, 2026

Researchers at IBBM (Instituto de Biotecnología y Biología Molecular) and NOVABIOMA Biomanufacturing FlexCo introduced ColabPCR, a Google Colab-based Python notebook created along with collaborators in Austria and Canada. It simplifies PCR primer design by combining Primer3 for primer selection, BLASTn for off-target detection, and restriction site insertion in a single platform. Validated on carrot genomes,…

Read More CoLabPCR: A One-stop Tool for Precise and Reproducible Primer Design
AI | Bioinformatics | Machine Learning | News | Paper Summary | Trending

From Variant to Disease: How V2P Improves Phenotype-Aware Pathogenicity Prediction
BySaniya Sayyed January 6, 2026October 22, 2026

Researchers at Mount Sinai Institute introduced Variant-to-Phenotype (V2P), a new machine learning framework that not only predicts whether a genetic variant is harmful but also reasons what kind of disease phenotype it leads to, making variant interpretation more precise and clinically useful. Explosion of Genetic Data and How it Transformed into Computational Approaches for Predicting…

Read More From Variant to Disease: How V2P Improves Phenotype-Aware Pathogenicity Prediction
Bioinformatics | News | Paper Summary | Tools | Trending

R2G2: Letting Bioconductor Fly in Galaxy Workflows
ByAnchal Negi January 4, 2026October 22, 2026

Researchers from the Center for Computational Life Sciences at the Cleveland Clinic introduce R2G2, a Python-R framework that automates the integration of R and Bioconductor tools into the Galaxy platform. As a bioinformatician who lives daily in RStudio, terminals, and Galaxy histories, this feels like someone just removed a chronic, low-grade headache from workflow development….

Read More R2G2: Letting Bioconductor Fly in Galaxy Workflows
AI | Bioinformatics | Drug Discovery | News | Paper Summary | Structural Biology | Tools | Trending

Designing Protein Binders with BoltzGen: A Unified Generative Approach
BySaniya Sayyed January 3, 2026October 22, 2026

Researchers at MIT introduce an all-atom generative model, BoltzGen. The model incorporates a design specification language that allows researchers to control constraints like covalent bonds, binding sites, and structural motifs for designing proteins and peptides that can bind to diverse biomolecular targets. With strong structural reasoning and state-of-the-art folding performance, BoltzGen is experimentally validated across…

Read More Designing Protein Binders with BoltzGen: A Unified Generative Approach
AI | Cancer | Deep Learning | Genomics | News | OMICS | Paper Summary | Tools | Trending

DeepSomatic: Redefining Somatic Variant Detection in the Genomic Sequencing Era
ByJainab Shaikh January 2, 2026October 22, 2026

Scientists at UC Santa Cruz, Google, the National Institutes of Health, and partner institutes have developed DeepSomatic, a deep-learning tool that detects cancer-related DNA alterations (somatic variations) from both short-read and long-read sequencing. Unlike other tools, it can operate with whole-genome, exome, tumor-normal, tumor-only, and FFPE samples. The team generated and publicly released five matched…

Read More DeepSomatic: Redefining Somatic Variant Detection in the Genomic Sequencing Era
AI | Bioinformatics | Deep Learning | News | Paper Summary | Proteomics | Trending

How SPURS Unlocks Scalable and Accurate Protein Stability Prediction
ByAnchal Negi December 31, 2025October 22, 2026

Protein engineering is in the middle of a quiet revolution, and a new study from researchers at the School of Computational Science and Engineering, Georgia Institute of Technology, pushes that revolution a big step forward, introducing SPURS (stability prediction using a rewired strategy). Their work, published in Nature Communications, tackles a longstanding challenge in computational…

Read More How SPURS Unlocks Scalable and Accurate Protein Stability Prediction
AI | Bioinformatics | Drug Discovery | Foundation Model | News | Paper Summary | Structural Biology | Trending

Placing Every Atom Right: PEARL’s Deep Learning Approach to Drug Discovery
ByAnchal Negi December 22, 2025October 22, 2026

Genesis Molecular AI and NVIDIA have introduced PEARL (Placing Every Atom in the Right Location), a deep learning foundation model designed for large-scale protein–ligand cofolding in computational drug discovery. By leveraging synthetic training data, SO(3)-equivariant diffusion architectures, and controllable inference, PEARL achieves more accurate and physically valid binding pose predictions, outperforming AlphaFold 3 and other leading…

Read More Placing Every Atom Right: PEARL’s Deep Learning Approach to Drug Discovery
AI | Bioinformatics | Foundation Model | Genomics | News | NGS | OMICS | Paper Summary | Trending

Agentic AI Meets RNA‑seq: A New Co‑Pilot For Downstream Analysis
ByAnchal Negi December 18, 2025October 22, 2026

Next-generation sequencing has transformed gene expression profiling into a routine experiment, but interpreting those matrices remains a challenge for many labs. Researchers from Kyungpook National University, Republic of Korea, address this gap by developing an “agentic” AI system that can plan, execute, and interpret RNA-sequencing downstream analysis for researchers with limited biological backgrounds. As a…

Read More Agentic AI Meets RNA‑seq: A New Co‑Pilot For Downstream Analysis
AI | Bioengineering | Bioinformatics | Machine Learning | News | Paper Summary | Protein Design

Minimal Data, Maximal Impact: The Future of Peptide Design with MDMI
ByDeotima Chakraborty December 5, 2025October 22, 2026

Peptides, which are short chains of amino acids, have become increasingly important in the world of medicine and biotechnology. Their unique properties make them ideal candidates for applications ranging from hormone therapies to antimicrobial agents. However, designing new, functional peptides has always been a challenge, primarily because traditional machine learning models require enormous datasets, often…

Read More Minimal Data, Maximal Impact: The Future of Peptide Design with MDMI
AI | Machine Learning | News | Paper Summary | Proteomics

Can Machine Learning Finally Crack the Protein Expression Code?
ByAnchal Negi December 4, 2025October 22, 2026

A team of researchers from the University of Edinburgh and collaborators from institutions like Stanford and UC San Francisco have tackled a central question in biotechnology: can we make protein expression predictable and routine? Their review, published in Trends in Biotechnology, explores why expressing proteins in host organisms remains a challenge, what’s holding the field…

Read More Can Machine Learning Finally Crack the Protein Expression Code?
AI | Genomics | News | OMICS | Paper Summary | Tools | Trending

AlphaGenome: DeepMind’s New AI Model for Unlocking Genome Function
ByAnchal Negi August 20, 2025October 22, 2026

Imagine holding a book written in a language where only 2% of the pages contain clear instructions, while the remaining 98% seem like indecipherable code. This mirrors the challenge scientists face with the human genome, where protein-coding regions make up a tiny fraction while non-coding regions control life’s essential processes. For decades, interpreting these regulatory…

Read More AlphaGenome: DeepMind’s New AI Model for Unlocking Genome Function
AI | Bioinformatics | Drug Discovery | Molecular Dynamics | News | Paper Summary | Structural Biology | Tools | Trending

From Boltz-1 to Boltz-2: Did We Finally Bridge the Gap Between Structure and Affinity?
ByDeotima Chakraborty June 10, 2025October 22, 2026

In modern biology, accurately simulating biomolecular interactions is a major difficulty. Our capacity to predict biomolecular complex structures has significantly improved with recent developments like AlphaFold3 and Boltz-1, yet these models are still unable to predict binding affinity, a crucial characteristic that underlies molecular function and therapeutic efficacy. Here, researchers from MIT introduce Boltz-2, a…

Read More From Boltz-1 to Boltz-2: Did We Finally Bridge the Gap Between Structure and Affinity?
AI | Bioinformatics | Deep Learning | News | Paper Summary | Structural Biology | Trending

D-I-TASSER Outperforms AlphaFold? A New Frontier in Protein Structure Modeling
ByDeotima Chakraborty May 29, 2025October 22, 2026

The requirement and utility of conventional force field-based folding simulations have been called into question by the overwhelming success of deep learning techniques in protein structure prediction. Researchers from the University of Michigan and the National University of Singapore presented a hybrid method called deep-learning-based iterative threading assembly refinement (D-I-TASSER), which combines iterative threading fragment…

Read More D-I-TASSER Outperforms AlphaFold? A New Frontier in Protein Structure Modeling
Bioinformatics | Drug Discovery | News | Paper Summary | Protein Design | Structural Biology | Tools | Trending

Unlocking Biomolecular Secrets with AF3Score: A Leap Forward in Structural Evaluation
ByAnchal Negi May 26, 2025October 22, 2026

Researchers from Changping Laboratory in Beijing introduced AF3Score, a novel adaptation of AlphaFold3 designed to evaluate biomolecular structures with unprecedented accuracy. This innovation addresses a critical gap in computational biology: the need for reliable, unbiased scoring methods to assess the quality of protein structures, complexes, and designed biomolecules. By reimagining AlphaFold3’s architecture, the team created…

Read More Unlocking Biomolecular Secrets with AF3Score: A Leap Forward in Structural Evaluation
AI | Bioinformatics | News | Paper Summary | Protein Design | Structural Biology | Trending

Overlapping Genes, Unfolding Insights: Synthetic Biology Meets AI
ByDeotima Chakraborty May 22, 2025October 22, 2026

Given that the sharing of codon nucleotides dramatically reduces the size of protein sequences, viruses in nature often generate overlapping genes (OLG) in alternate reading frames of the same nucleotide sequence. The question of whether amino acid sequences are sufficiently degenerate with regard to protein folding to permit the extensive overlap of arbitrary pairs of…

Read More Overlapping Genes, Unfolding Insights: Synthetic Biology Meets AI
AI | Bioinformatics | Deep Learning | Drug Discovery | News | Paper Summary | Structural Biology | Trending

PhysDock: A New Era in Protein-Ligand Docking with AI and Physics
ByAnchal Negi May 19, 2025October 22, 2026

In a breakthrough that could transform drug discovery, a team of researchers from ShanghaiTech University has introduced PhysDock, a novel AI-powered model designed to predict how small molecules (ligands) bind to proteins with atomic-level precision. Protein-ligand docking plays a central role in structure-based drug design. It helps researchers understand how drugs interact with their biological…

Read More PhysDock: A New Era in Protein-Ligand Docking with AI and Physics
AI | Bioinformatics | News | Paper Summary | Structural Biology | Tools | Trending

Advancing Enzyme Design: RFdiffusion2 Enables Atomic-Level Scaffold Generation
ByDeotima Chakraborty May 15, 2025October 22, 2026

In de novo enzyme design, the functional groups surrounding reaction transition states are described in the optimal active site. There are drawbacks to the generative AI technique RFdiffusion, which has been used to build highly active enzymes. The active site’s geometry can only be defined at the residue level, necessitating the construction of side chain…

Read More Advancing Enzyme Design: RFdiffusion2 Enables Atomic-Level Scaffold Generation
AI | Bioinformatics | Drug Discovery | News | Paper Summary | Structural Biology | Trending

Building Better Models: How AI and Experimentation Shape GPCR Research in AlphaFold Era
ByDeotima Chakraborty April 30, 2025October 22, 2026

The GPCR Dock competitions are a set of community-wide evaluations of ligand docking and computational structural modeling for G protein-coupled receptors, a key class of therapeutic targets in the human proteome. To shape and guide the development of computational modeling approaches for GPCRs, the assessments are intended to offer an objective summary of advancements and…

Read More Building Better Models: How AI and Experimentation Shape GPCR Research in AlphaFold Era
AI | Bioinformatics | Deep Learning | Drug Discovery | News | Paper Summary | Structural Biology | Trending

Fast, Accurate, and Flexible: How FLOWR is Transforming Molecular Design
ByAnchal Negi April 23, 2025October 22, 2026

In a recent breakthrough in AI-driven drug discovery, researchers from Pfizer, AstraZeneca, and Chalmers University unveiled a new generative framework called FLOWR, designed to revolutionize structure-based ligand generation. Their collaborative work bridges machine learning, computational chemistry, and pharmaceutical research and is set to address some of the most persistent challenges in early-stage drug design. Why…

Read More Fast, Accurate, and Flexible: How FLOWR is Transforming Molecular Design
Bioinformatics | Drug Discovery | News | Paper Summary | Protein Design | Structural Biology | Trending

Designer Miniproteins: New Frontier in GPCR-Targeted Drug Development
ByDeotima Chakraborty April 14, 2025October 22, 2026

G protein-coupled receptors (GPCRs) are essential membrane proteins with dynamic conformations that are also major targets for drug development and discovery. However, designing protein agonists and antagonists has proven difficult. In this article, researchers outline computational de novo design techniques and a high throughput “receptor diversion” microscopy-based screen for producing GPCR binding miniproteins with high…

Read More Designer Miniproteins: New Frontier in GPCR-Targeted Drug Development
AI | Bioinformatics | LLM | News | Paper Summary | Trending

Meet AgentRxiv: A Collaborative Framework for AI Research Agents to Accelerate Discovery
ByDeotima Chakraborty April 13, 2025October 22, 2026

Hundreds of scientists come together through collaborative efforts to accomplish a shared goal during scientific discovery processes. Current workflows generate research independently, yet they cannot continually enhance previous discoveries because researchers work separately from one another. AgentRxiv, introduced by researchers from Johns Hopkins University and ETH Zurich, presents a system that solves these challenges by…

Read More Meet AgentRxiv: A Collaborative Framework for AI Research Agents to Accelerate Discovery
AI | Bioinformatics | Deep Learning | Drug Discovery | Molecular Dynamics | News | Paper Summary | Structural Biology | Trending

MolAI: The Deep Learning Model Transforming Molecular Descriptor Generation
ByAnchal Negi April 12, 2025October 22, 2026

Recent years have witnessed significant advancements in the fields of artificial intelligence (AI) and machine learning (ML), catalyzing a revolution in cheminformatics and drug discovery. These advancements have enabled scientists to predict molecular properties, design novel compounds with desired characteristics, and estimate drug/bio-macromolecular interactions with unprecedented accuracy. At the heart of these breakthroughs lies the…

Read More MolAI: The Deep Learning Model Transforming Molecular Descriptor Generation

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Paper Summary

Minimal Data, Maximal Impact: The Future of Peptide Design with MDMI

Can Machine Learning Finally Crack the Protein Expression Code?

Training

Services

Resources

Company